# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4792750 | Cl-39 | EC50 | = | 3.7 | uM | ALA4767771 | 5.43 | nM | Coxsackievirus B3 | ||
2. | ALA4792750 | Cl-39 | EC50 | = | 0.95 | uM | ALA4767770 | 6.02 | nM | Human alphaherpesvirus 1 | ||
3. | ALA4792750 | Cl-39 | EC50 | = | 2.59 | uM | ALA4767769 | 5.59 | nM | Influenza A virus H3N2 | ||
4. | ALA4792750 | Cl-39 | Ratio EC50 | = | 1.2 | ALA4767768 | ||||||
5. | ALA4792750 | Cl-39 | Ratio EC50 | = | 0.9 | ALA4767767 | ||||||
6. | ALA4792750 | Cl-39 | Ratio EC50 | = | 1 | ALA4767766 | ||||||
7. | ALA4792750 | Cl-39 | Ratio EC50 | = | 0.6 | ALA4767765 | ||||||
8. | ALA4792750 | Cl-39 | Ratio EC50 | = | 0.9 | ALA4767764 | ||||||
9. | ALA4792750 | Cl-39 | Ratio EC50 | = | 0.7 | ALA4767763 | ||||||
10. | ALA4792750 | Cl-39 | Ratio EC50 | = | 0.9 | ALA4767762 | ||||||
11. | ALA4792750 | Cl-39 | EC50 | = | 4.07 | uM | ALA4767761 | 5.39 | nM | Human immunodeficiency virus 1 | ||
12. | ALA4792750 | Cl-39 | EC50 | = | 3.19 | uM | ALA4767760 | 5.50 | nM | Human immunodeficiency virus 1 | ||
13. | ALA4792750 | Cl-39 | EC50 | = | 3.27 | uM | ALA4767759 | 5.49 | nM | Human immunodeficiency virus 1 | ||
14. | ALA4792750 | Cl-39 | EC50 | = | 2.14 | uM | ALA4767758 | 5.67 | nM | Human immunodeficiency virus 1 | ||
15. | ALA4792750 | Cl-39 | EC50 | = | 3.08 | uM | ALA4767757 | 5.51 | nM | Human immunodeficiency virus 1 | ||
16. | ALA4792750 | Cl-39 | EC50 | = | 2.41 | uM | ALA4767756 | 5.62 | nM | Human immunodeficiency virus 1 | ||
17. | ALA4792750 | Cl-39 | Activity | = | 51.95 | % | ALA4767752 | % | Homo sapiens | |||
18. | ALA4792750 | Cl-39 | IC50 | > | 30 | uM | ALA4767749 | nM | ||||
19. | ALA4792750 | Cl-39 | EC50 | = | 3 | uM | ALA4767748 | 5.52 | nM | Human immunodeficiency virus 1 | ||
20. | ALA4792750 | Cl-39 | IC50 | = | 7.2 | uM | ALA4767747 | 5.14 | nM |